Elite Pharmaceuticals Inc (ELTP)
0.6146
0.00 (0.00%)
USD |
OTCM |
Nov 22, 12:40
Elite Pharmaceuticals Price to Book Value: 13.89 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 13.96 |
| November 20, 2024 | 15.00 |
| November 19, 2024 | 15.26 |
| November 18, 2024 | 15.04 |
| November 15, 2024 | 12.69 |
| November 14, 2024 | 11.70 |
| November 13, 2024 | 13.00 |
| November 12, 2024 | 12.66 |
| November 11, 2024 | 12.23 |
| November 08, 2024 | 11.52 |
| November 07, 2024 | 11.30 |
| November 06, 2024 | 11.64 |
| November 05, 2024 | 11.52 |
| November 04, 2024 | 11.53 |
| November 01, 2024 | 11.33 |
| October 31, 2024 | 10.01 |
| October 30, 2024 | 9.831 |
| October 29, 2024 | 11.53 |
| October 28, 2024 | 12.86 |
| October 25, 2024 | 12.21 |
| October 24, 2024 | 13.01 |
| October 23, 2024 | 10.63 |
| October 22, 2024 | 13.56 |
| October 21, 2024 | 15.93 |
| October 18, 2024 | 13.22 |
| Date | Value |
|---|---|
| October 17, 2024 | 11.30 |
| October 16, 2024 | 10.96 |
| October 15, 2024 | 9.958 |
| October 14, 2024 | 9.447 |
| October 11, 2024 | 9.825 |
| October 10, 2024 | 9.185 |
| October 09, 2024 | 9.038 |
| October 08, 2024 | 9.115 |
| October 07, 2024 | 9.006 |
| October 04, 2024 | 8.853 |
| October 03, 2024 | 8.817 |
| October 02, 2024 | 9.487 |
| October 01, 2024 | 8.767 |
| September 30, 2024 | 8.769 |
| September 27, 2024 | 7.152 |
| September 26, 2024 | 7.133 |
| September 25, 2024 | 7.116 |
| September 24, 2024 | 6.943 |
| September 23, 2024 | 6.867 |
| September 20, 2024 | 6.840 |
| September 19, 2024 | 7.132 |
| September 18, 2024 | 7.106 |
| September 17, 2024 | 7.015 |
| September 16, 2024 | 7.149 |
| September 13, 2024 | 6.604 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9644
Minimum
Mar 14 2023
15.93
Maximum
Oct 21 2024
2.851
Average
2.471
Median
Aug 13 2021
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.263 |
| BioCardia Inc | 3.830 |
| Zevra Therapeutics Inc | 7.298 |
| Verrica Pharmaceuticals Inc | -- |
| Terns Pharmaceuticals Inc | 1.345 |
Price to Book Value Related Metrics
| PS Ratio | 9.075 |
| Price to Free Cash Flow | 383.32 |
| Price | 0.6146 |
| Earnings Yield | -1.42% |
| Market Cap | 656.56M |
| Operating PE Ratio | 44.20 |
| Normalized PE Ratio | 170.16 |